UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer research (Chicago, Ill.), ISSN 0008-5472, 11/2017, Volume 77, Issue 22 Supplement, pp. IA25 - IA25
Journal Article
Journal of hepatology, ISSN 0168-8278, 01/2018, Volume 68, Issue 1, pp. 157 - 166
Journal Article
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 12/2015, Volume 12, Issue 12, pp. 681 - 700
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Neoplasms - immunology | Immunotherapy - methods | Carcinoma, Hepatocellular - immunology | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Humans | Radiofrequency ablation | Usage | Care and treatment | Hepatoma | Immunotherapy | Risk factors | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 04/2018, Volume 24, Issue 7, pp. 1518 - 1524
Life Sciences & Biomedicine | Oncology | Science & Technology | PD-1 protein | Clinical trials | Cytotoxicity | Hepatocellular carcinoma | Lymphocytes T | Patients | Immunosuppressive agents | Anticancer properties | Proteins | Liver cancer | CTLA-4 protein | Inhibitors | Immune checkpoint | Cell death | Immunotherapy | Monoclonal antibodies | Biomarkers | Antitumor activity | Synergistic effect | Tumors | Cancer | Apoptosis | Immune system
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10088, pp. 2492 - 2502
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Administration Schedule | Humans | Antibodies, Monoclonal - adverse effects | Liver Neoplasms - drug therapy | Male | Response Evaluation Criteria in Solid Tumors | Treatment Outcome | Antineoplastic Agents - administration & dosage | Tumor Burden | Dose-Response Relationship, Drug | B7-H1 Antigen - metabolism | Carcinoma, Hepatocellular - drug therapy | Time Factors | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Nivolumab | Carcinoma, Hepatocellular - pathology | Biomarkers, Tumor - metabolism | Female | Liver Neoplasms - pathology | Aged | Virus diseases | Medical colleges | Care and treatment | Cell death | College teachers | Hepatoma | Comparative analysis | Drug approval | Therapy | Pemphigoid | Intravenous administration | Inhibitor drugs | PD-1 protein | Funding | Liver | Clinical trials | Hepatocellular carcinoma | Lymphocytes T | Infections | Metastasis | Dosage | Cancer therapies | B7 antigen | Acceptability | Incidence | Hepatitis | Liver cancer | Pathways | Quality | Immunotherapy | Safety management | Safety | Expansion | Drug dosages | Liver diseases | Effectiveness | Mortality | Group dynamics | Patients | Hospitals | Inhibitors | Immune checkpoint | Adults | Solid tumors | Hepatitis C virus | Hepatitis C | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Seminars in liver disease, ISSN 0272-8087, 11/2014, Volume 34, Issue 4, pp. 435 - 443
radioembolization | selective internal radiation therapy | yttrium | transarterial chemoembolization | drug-eluting bead transarterial chemoembolization | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Treatment Outcome | Liver Neoplasms - therapy | Embolization, Therapeutic - adverse effects | Patient Selection | Liver Neoplasms - blood supply | Carcinoma, Hepatocellular - pathology | Carcinoma, Hepatocellular - blood supply | Chemoembolization, Therapeutic - adverse effects | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - therapy | Radiopharmaceuticals - adverse effects | Embolization, Therapeutic - methods | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 12/2013, Volume 58, Issue 6, pp. 2188 - 2197
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Chemoembolization, Therapeutic - methods | Liver Transplantation | Humans | Liver Neoplasms - radiotherapy | Middle Aged | Carcinoma, Hepatocellular - radiotherapy | Male | Aged | Clinical Trials as Topic | Yttrium Radioisotopes - therapeutic use | Index Medicus | radioembolization | randomized trial | hepatocellular carcinoma
Journal Article
Baillière's best practice & research. Clinical gastroenterology, ISSN 1521-6918, 2014, Volume 28, Issue 5, pp. 909 - 919
Gastroenterology and Hepatology | Radioembolization, RE | Yttrium | Transarterial chemoembolization, TACE | Drug-eluting beads, DEB | Selective Internal Radiation Therapy, SIRT | DEB | Selective internal radiation therapy | Transarterial chemoembolization | TACE | Drug-eluting beads | Radioembolization | SIRT | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Radiopharmaceuticals - administration & dosage | Carcinoma, Hepatocellular - therapy | Liver Neoplasms - therapy | Antineoplastic Agents - administration & dosage | Humans | Embolization, Therapeutic - methods | Index Medicus
Journal Article
Future oncology (London, England), ISSN 1479-6694, 11/2014, Volume 10, Issue 15, pp. 7 - 11
selective internal radiation therapy | hepatocellular carcinoma | brachytherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Evidence-Based Practice | Chemoembolization, Therapeutic | Humans | Liver Neoplasms - radiotherapy | Brachytherapy - methods | Carcinoma, Hepatocellular - pathology | Carcinoma, Hepatocellular - radiotherapy | Liver Neoplasms - pathology | Palliative Care | Disease Management
Journal Article